Posts by Cory
Challenges With Buprenorphine Initiation in the Fentanyl Era—Adapting Effectively to the Moment
Buprenorphine is a cornerstone medication for opioid use disorder (OUD) but carries a known risk of precipitated withdrawal (PW) during initiation, a concern that appears to be increasing in the era of nonpharmaceutical fentanyl (NPF). Kawasaki and colleagues report findings from a 2023–2024 nationally representative survey of 396 US buprenorphine prescribers examining challenges with buprenorphine…
Read MoreFellow Spotlight: Damian Chase-Begay, PhD, MS
For Damian Chase-Begay, Ph.D., M.S. (Mandan/Arikara), public health was shaped early by family, community, and lived experience. Born in Missoula, Montana, his path traces back to the 1960s, when his grandmother came to the University of Montana on a tribal scholarship, earned a degree in nutrition, and went on to become a nurse serving Native communities. Exposure to Indian Health systems was part of daily life. “There wasn’t a moment where I decided this is what I’d do,” he says. “It was always there.”
Read MoreImplementation Outcomes Included in NIDA Clinical Trials Network (CTN) Studies: A Systematic Review of Studies Conducted Over 20 Years
The National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) has supported clinical trials of substance use disorder (SUD) interventions for 25 years. This review describes the use of implementation outcomes across CTN trials, characterizes outcomes included, and identifies gaps and potential opportunities to strengthen implementation research within the CTN and the field of…
Read MoreFaculty Spotlight: Erika Crable, PhD, MPH
For Erika Crable, PhD, MPH, implementation science is personal. Growing up in the D.C. and Baltimore areas, she witnessed how the “three waves” of the U.S. opioid epidemic—the prescription drug crisis of the 1990s, the rise of heroin in the 2000s, and the spread of synthetic opioids in the years since— devastated families and communities, including her own.
Read MoreNot Just for Snacks – Vending Machines as a Low-Barrier Harm Reduction Access Method
Alice Zhang, MD, MPH | January 6, 2026 : Harm reduction-focused vending machines, delivering naloxone, fentanyl test strips, and other public health items, represent a potential non-stigmatizing, low-barrier approach to harm reduction that may increase access and engagement with underserved populations, reduce overdoses and related public health conditions, and health disparities in substance use disorder.…
Read MoreFellow Spotlight: Enya Vroom, PhD
If you ask Dr. Enya Vroom what makes her unique, she might skip the professional milestones and offer something lighter: she, her sister, and her brother all share the same birthday — same day, different years. “We’re not triplets,” she’ll assure you. “Just a statistical anomaly.”
Read MoreFall 2025 C-DIAS Newsletter
Welcome to this issue of the C-DIAS newsletter!
Read More“Beyond the False Dichotomy” Bridging the MOUD-Mutual Help Group Divide
Wayne Kepner, PhD, MPH | November 18 2025 : A significant barrier to addressing the opioid crisis is the “false dichotomy” between two of our most effective strategies; medications for opioid use disorder (MOUD) and 12-step mutual help groups (MHG). MOUD is the most effective pharmacological treatment to reduce mortality, while MHGs provide invaluable access…
Read MoreFellow Spotlight: Crystal Lederhos Smith, PhD
Dr. Crystal Smith’s path into addiction science didn’t begin in a lab or clinic. It began in a rural logging town in northern Idaho, a community shaped by poverty, limited opportunity, and the kinds of challenges that can derail a young person before adulthood. Smith understands this firsthand.
Read MoreHow to Work Your Data Project into a Health Care System: An HD2A Story
Niranjan S. Karnik, M.D., Ph.D. | November 4, 2025 : Translating data science innovations into real-world clinical impact remains a critical challenge in healthcare. This talk presents the story of C-DOSETaP (Chicago Data-Driven OUD Screening, Engagement, Treatment and Prevention) project, a NIDA-funded initiative under the Helping to End Addiction Long-term Data to Action (HD2A) program.…
Read More